DEFINITION: A path through the study which describes what activities the study subject or experimental unit will be involved in as they pass through the study, and is typically equivalent to a treatment group in a parallel design trial. Generally, each subject is assigned to an arm, and the design of the study is reflected in the number and composition of the individual arms. This intended path through which the subject progresses in a trial is composed of time point events for each epoch of the study. Each time point event, in turn, has a pattern of child time points through which the subject would pass. This planned path thus describes how subjects assigned to the arm will be treated. EXAMPLE(S): A study could have 2 arms named IV-Oral and Oral-IV.  The name IV-Oral reflects a path that passes through IV treatment, then Oral treatment. OTHER NAME(S): Group (CTRR Observational Studies)

http://purl.org/net/OCRe/study_protocol.owl#OCRE300001

DEFINITION: A path through the study which describes what activities the study subject or experimental unit will be involved in as they pass through the study, and is typically equivalent to a treatment group in a parallel design trial. Generally, each subject is assigned to an arm, and the design of the study is reflected in the number and composition of the individual arms. This intended path through which the subject progresses in a trial is composed of time point events for each epoch of the study. Each time point event, in turn, has a pattern of child time points through which the subject would pass. This planned path thus describes how subjects assigned to the arm will be treated. EXAMPLE(S): A study could have 2 arms named IV-Oral and Oral-IV.  The name IV-Oral reflects a path that passes through IV treatment, then Oral treatment. OTHER NAME(S): Group (CTRR Observational Studies)

Simona

BRIDG 3.0.3 Available at http://bridgmodel.nci.nih.gov/

Arm

study_protocol:OCRE300001

OCRE300001

Arm

http://purl.org/net/OCRe/OCRe.owl#OCRE400032